What is the approach to managing hyponatremia (low sodium levels)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Approach to Hyponatremia

The management of hyponatremia should follow a systematic approach based on volume status assessment, severity of symptoms, and rate of sodium correction to prevent complications like osmotic demyelination syndrome. 1

Initial Assessment

Severity Classification

  • Mild: 126-135 mEq/L (often asymptomatic)
  • Moderate: 120-125 mEq/L (nausea, headache, confusion)
  • Severe: <120 mEq/L (risk of seizures, coma, respiratory arrest) 1

Volume Status Assessment

Volume status is critical for determining the underlying cause and treatment approach:

Volume Status Clinical Signs Urine Sodium Likely Causes
Hypovolemic Orthostatic hypotension, dry mucous membranes, tachycardia <20 mEq/L GI losses, diuretics, adrenal insufficiency
Euvolemic No edema, normal vital signs >20-40 mEq/L SIADH, hypothyroidism, adrenal insufficiency
Hypervolemic Edema, ascites, elevated JVP <20 mEq/L Heart failure, cirrhosis, renal failure

Diagnostic Criteria for SIADH

  • Hyponatremia (serum sodium < 134 mEq/L)
  • Hypoosmolality (plasma osmolality < 275 mosm/kg)
  • Inappropriately high urine osmolality (> 500 mosm/kg)
  • Inappropriately high urinary sodium concentration (> 20 mEq/L)
  • Absence of hypothyroidism, adrenal insufficiency, or volume depletion 3

Treatment Algorithm

Severe Symptomatic Hyponatremia (Seizures, Coma, Respiratory Distress)

  1. Immediate intervention with 3% hypertonic saline:

    • Administer as 100-150 mL bolus or continuous infusion 4
    • Goal: Increase serum sodium by 4-6 mEq/L within 1-2 hours to reverse life-threatening symptoms 2
    • Maximum correction: 8 mEq/L in 24 hours to prevent osmotic demyelination syndrome 1
  2. Monitoring:

    • Check sodium levels every 2 hours initially, then every 4 hours 1
    • If correction exceeds 8 mEq/L/day, consider desmopressin administration to slow correction 4

Moderate Symptomatic Hyponatremia

  1. Fluid restriction to 1-1.5 L/day for serum sodium <125 mmol/L 1
  2. Treatment based on volume status:
    • Hypovolemic: Normal saline infusion 5
    • Euvolemic: Fluid restriction, consider tolvaptan or urea if fluid restriction fails 4
    • Hypervolemic: Treat underlying condition (heart failure, cirrhosis), fluid restriction, consider diuretics 1, 5

Mild to Moderate Asymptomatic Hyponatremia

  1. Address underlying cause (medication review, treat primary disease)
  2. Volume status-based approach:
    • Hypovolemic: Normal saline infusion
    • Euvolemic: Moderate fluid restriction (1-1.5 L/day)
    • Hypervolemic: Fluid restriction, sodium restriction, diuretics 1, 2

Special Considerations

Tolvaptan Use

  • Indication: Short-term treatment (≤30 days) for euvolemic or hypervolemic hyponatremia 6
  • Starting dose: 15 mg once daily 1
  • Monitoring: Watch for overly rapid correction and hypernatremia 6
  • Caution: Avoid in patients with liver disease due to risk of liver injury 6

Cirrhosis-Related Hyponatremia

  • For sodium levels 126-135 mmol/L with normal creatinine: Continue diuretic therapy with close electrolyte monitoring 1
  • For sodium levels 121-125 mmol/L: Consider stopping diuretics 1
  • For sodium levels <120 mmol/L: Stop diuretics and consider volume expansion 1
  • Tolvaptan should be used cautiously as gastrointestinal bleeding was reported in 10% of cirrhotic patients vs. 2% in placebo group 6

Prevention of Osmotic Demyelination Syndrome

  • Maximum correction rate: 8 mEq/L in 24 hours 1
  • Risk factors: Chronic alcoholism, malnutrition, liver disease, hypokalemia 2
  • If correction exceeds recommended rate, consider administering desmopressin and/or hypotonic fluids 4

Monitoring and Follow-up

  • Frequent monitoring of serum sodium levels during active correction
  • Continue monitoring after normalization to ensure stability
  • Assess for neurological symptoms that might indicate osmotic demyelination syndrome
  • Evaluate effectiveness of treatment of underlying conditions 1, 4

Remember that untreated severe hyponatremia carries a mortality rate of 25% compared to 9.3% when sodium levels are >120 mEq/L, highlighting the importance of prompt but careful management 1.

References

Guideline

Management of Cirrhosis and Ascites

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Hyponatraemia-treatment standard 2024.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2024

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.